Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1951881Generated: November 4, 2026

(1E)-(Hept-1-en-1-yl)boronic acid → 5-{3-[4-(2,4-Dichloro-phenyl)-2-(4-hept-1-enyl-benzyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxide

https://huagongshe.com/reaction/1951881

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(1E)-(Hept-1-en-1-yl)boronic acidHCID 5708385—
Reactant5-{3-[2-(4-Bromo-benzyl)-4-(2,4-dichloro-phenyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxideHCID 59305509—
Product5-{3-[4-(2,4-Dichloro-phenyl)-2-(4-hept-1-enyl-benzyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxideHCID 68584301—

Reaction Steps

5-{3-[2-(4-Bromo-benzyl)-4-(2,4-dichloro-phenyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxide (59 mg, 0.1 mmol) was treated as described in general procedure G using trans-1-heptenylboronic acid (43 mg, 0.3 mmol) to give 5-{3-[4-(2,4-dichloro-phenyl)-2-(4-hept-1-enyl-benzyl)-imidazol-1-yl]-phenyl}-1,2,5-thiadiazolidine-3-one-1,1-dioxide.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08404731B2
Source datasetuspto-grants-2013_03
ORD IDord-3890a57b7a8d4ecfa4a027561325f399
Source noteuspto-grants-2013_03